2020 ISPE APAC Pharma Manufacturing Virtual Conference

Sep 21, 2020 ‐ Sep 23, 2020


The 2020 ISPE Asia Pacific Pharmaceutical Manufacturing Virtual Conference and Executive Forum provides you with access to regulatory intelligence on emerging supply chain, quality, and compliance challenges in light of COVID-19. Participate in actionable, interactive discussions featuring case studies and dedicated Q&A time with experts representing global health authorities, including FDA and MHRA.

Benefit from unparalleled real-time engagement with regulatory leaders as they share companies' best practices to assess critical manufacturing processes and lessons learned to improve and sustain a reliable supply of quality medicine. Plus, stay knowledgeable throughout the year with on demand access to ALL session recordings and presentations for 12 months.


Sessions

EXPO-Exhibit Showcase/Poster Presentations

Sep 21, 2020 4:30am ‐ Sep 21, 2020 6:30am

Identification: AP20CESEP1/SESEXPO

EXPO-Exhibit Showcase/Poster Presentations | Visit the EXPO to explore virtual exhibits showcasing the latest equipment and services. Professional poster presentations will be available for viewing throughout the conference.

Speaker(s):

A Holistic Evaluation of Blockchain Technologies Integration into the Bio/Pharmaceutical Industry to Evolve with Future Demands’

Sep 21, 2020 4:30am ‐ Sep 21, 2020 6:30am

Identification: CM-SESEXPO1

Speaker(s):

Twelve Biggest CAPA Opportunities

Sep 21, 2020 4:30am ‐ Sep 21, 2020 6:30am

Identification: CM-SESEXPO2

Speaker(s):

Executive Forum - Trends in Supply Chain Visibility & Control - Part 1

Sep 21, 2020 7:30am ‐ Sep 21, 2020 9:00am

Identification: AP20CESEP1/SESP1

Executive Forum - Trends in Supply Chain Visibility & Control - Part 1 | The Executive Forum, led by global regulators and industry leaders, is an interactive discussion forum for pharmaceutical executives. The focus of this year's Forum will be on assessing the impact of COVID-19 on the pharmaceutical supply chain and lessons learned for the pharmaceutical manufacturing industry.

Session Leader(s): Speaker(s):

Update on Collaboration Efforts with India Regulators

Sep 21, 2020 7:35am ‐ Sep 21, 2020 7:45am

Identification: CM-SESP1.a

Speaker(s):

Impact of COVID-19 on the Pharmaceutical Supply Chain

Sep 21, 2020 7:45am ‐ Sep 21, 2020 8:10am

Identification: CM-SESP1.b

Speaker(s):

Impact of COVID-19 on the Pharmaceutical Supply Chain

Sep 21, 2020 7:45am ‐ Sep 21, 2020 8:10am

Identification: CM-SESP1.c

Speaker(s):

Regulatory Flexibility during COVID-19

Sep 21, 2020 8:10am ‐ Sep 21, 2020 8:25am

Identification: CM-SESP1.d

Speaker(s):

An Update on Alternate Approaches and Cross-Agency Communication

Sep 21, 2020 8:25am ‐ Sep 21, 2020 8:35am

Identification: CM-SESP1.e

Speaker(s):
  • Carmelo Rosa, PsyD, Director, Division of Drug Quality I, FDA/CDER/OC/OMQ

Supply Chain Security in Times of Crisis

Sep 21, 2020 8:35am ‐ Sep 21, 2020 9:00am

Identification: CM-SESP1.f

Speaker(s):
Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content